GMP issues affect Mircera, Xenical production at Roche plant InPharm Roche said it has stopped releasing batches of weight-loss treatment Xenical (orlistat) and red blood cell stimulator Mircera (methoxy polyethylene glycol-epoetin beta) made at the 300000 sq. ft. plant in Florence, South Carolina, because of the GMP ... |
Continue Reading 01/31/2012
ABPI: No plans to issue social media rules; Roche meds Mircera, Xenical may ... FiercePharma Report > Roche drugs Mircera and Xenical may run short in some countries because of manufacturing problems at a US plant, the company said. News > Delaware lawmakers introduced a bill that would require insurance companies to charge similar co-pays for ... |
Continue Reading 01/27/2012
Roche Pharmaceutical Plant In US Hit By Production Problems Wall Street Journal (India) The company is no longer releasing its anaemia drug Mircera and Xenical obesity drug to the market after the problems were discovered at the factory in Florence, South Carolina. The factory produces ingredients for the two drugs as well as for other ... Supply of two Roche drugs in question, US plant trouble |
Continue Reading 01/25/2012
Roche plant spared from sale runs into GMP issues FiercePharma Manufacturing A South Carolina plant Roche ($RHHBY) had on the auction block last year has developed manufacturing issues that have interrupted production of its weight control drug Xenical. Health officials in the US and Europe have been notified, and the Swiss ... |
Continue Reading 02/02/2012
Mircera in short supply Dispensing Doctors' Association By Ailsa Colquhoun Roche has warned that Xenical 120mg and Mircera Pre-filled Syringe, methoxy polyethylene glycol-epoetin beta will be out of stock until mid-March at the earliest, due to manufacturing problems. In a statement issued to PSNC, ... |
Continue Reading 02/02/2012
Arena Pharmaceuticals Has Over A 300% Upside Potential In 2012 Seeking Alpha PK), which markets Xenical or GlaxoSmithKline Consumer Healthcare (GSK) which markets an over-the-counter low-dose version of Orlistat (same active ingredient as Xenical) in the United States under the brand name Alli. Xenical/Orlistat have the ... |
Continue Reading 01/29/2012
 Health24.com | Meds that affect nutrient intake Health24.com Slimming drugs containing orlistat such as Xenical and Alli, interfere with lipase enzyme activity and reduce fat uptake by the gut. This can also reduce the uptake of fat-soluble vitamins A, D, E and K, with resulting deficiencies (Mahan LK et al, ... |
Continue Reading 01/23/2012
Study reveals counterfeit medicine patterns in Brazil Securing Pharma Other drugs seized with lower frequency including fake versions of Pfizer's prostaglandin product Cytotec (misoprostol), Novartis' cancer treatment Gleevec (imatinib) and Roche's obesity drug Xenical (orlistat). Over the four-year period, ... |
Continue Reading 01/17/2012
Vivus' Obesity Drug Label Modified Daily Markets The obesity treatments currently in the market include orlistat, sold by Roche Holdings Ltd. (RHHBY) as Xenical and by GlaxoSmithKline (NYSE:GSK) as Alli. We currently have a Neutral recommendation on Vivus. The stock carries a Zacks #3 Rank (Hold ... |
Continue Reading 01/12/2012
 In-PharmaTechnologist.com | Manufacturing issues round-up In-PharmaTechnologist.com Shortages for the medication in question â Mircera, an anaemia drug, and weight loss treatment Xenical â would only affect some countries, and authorities have not demanded a recall. The problems, which have not yet been specified, were discovered ... |
Continue Reading 01/26/2012